REGISTERED
on 01 Jun 2021
Last Applicant/ Owned by
555 Marriott Dr, Ste 315
Nashville
TN
37214
Serial Number
88633302 filed on 27th Sep 2019
Registration Number
6367315 registered on 01st Jun 2021
Correspondent Address
Nyall Engfield
Filing Basis
1. use application currently
Disclaimer
NO DATA
A2A INTEGRATED PHARMACEUTICALS
Ophthalmic preparations; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders
Classification Information
Class [005]
Pharmaceutical Products
Ophthalmic preparations; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders
First Use Date in General
01st Jul 2019
First Use Date in Commerce
01st Jul 2019
Mark Details
Serial Number
No 88633302
Mark Type
No Service/Collective Mark
Attorney Docket Number
No A2A-001
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 01st Jun 2021 | REGISTERED-PRINCIPAL REGISTER |
| 16th Mar 2021 | PUBLISHED FOR OPPOSITION |
| 16th Mar 2021 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 24th Feb 2021 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 05th Feb 2021 | ELECTRONIC RECORD REVIEW COMPLETE |
| 22nd Jan 2021 | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED |
| 20th Jan 2021 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 19th Jan 2021 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 19th Jan 2021 | ASSIGNED TO LIE |
| 19th Jan 2021 | CORRESPONDENCE RECEIVED IN LAW OFFICE |